Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Sanofi to Cut Hundreds of Jobs in Europe

By Drug Discovery Trends Editor | February 3, 2016

​Sanofi alerted labor unions this morning it plans to cut an estimated 600 jobs from its headquarters in France. The drugmaker employs a quarter of its staff — 27,000 people — in Paris.

The reduction is expected to take place over the course of three years, reports Bloomberg. The company did not yet indicate a date when layoffs would begin.

Sanofi union representative Thierry Bodin told the publication the cuts will eliminate 296 research and development positions that were to be filled, along with 155 jobs in the company’s commercial operations department and more than 100 corporate roles that will affect central and support functions.

Olivier Brandicourt, Sanofi’s CEO, is implementing this measure as a way to trim costs and maintain growth through 2020. The drugmaker’s large diabetes business is facing pricing problems and competition from generics for its profitable Lantus insulin, which is the third best-selling medicine in this category.

Sanofi said layoffs will also take place outside of France. The company has more than 110,000 employees in 100 countries, according to its website. Sanofi may announce more details during its earnings call on February 9. 


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE